FDA
-
-
-
-
-
-
-
OncoCyte (OCX) Provides Positive Update on Clinical Trial Progress
-
-
-
-
-
-
-
Oncocyte Prices $29.1 Million Equity Offering
-
-
-
-
-
-
-
Oncocyte Announces Successful GraftAssure™ Beta Launch and Q2 2024 Results
-
-
-
-
-
-
-
OncoCyte Corp (OCX) PT Lowered to $5 at Needham & Company
-
-
-
-
-
-
-
Rockwell Medical Announces Appointment of Russell L. Skibsted as Executive Vice President, Chief Financial Officer and Chief Business Officer
-
-
-
-
-
-
-
BioTime Reports Second Quarter Results and Recent Corporate Accomplishments
-
-
-
-
-
-
-
BioTime Reports First Quarter Results and Recent Corporate Accomplishments
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

